Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Aprepitant |
| Component 1: | |
| Active Ingredient: | Aprepitant 80mg |
| Dosage Form: | Capsule |
| Component 2: | |
| Active Ingredient: | Aprepitant 125mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Alchemy Health Limited |
| Manufacturer: | Pharmathen International SA, Rodopi, Greece |
| Product: | Aprepitant |
| Active Ingredient: | Aprepitant 40mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Alchemy Health Limited |
| Manufacturer: | Pharmathen International SA, Rodopi, Greece |
| Product: | Aprepitant |
| Active Ingredient: | Aprepitant 80mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Alchemy Health Limited |
| Manufacturer: | Pharmathen International SA, Rodopi, Greece |
| Product: | Aprepitant |
| Active Ingredient: | Aprepitant 125mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Alchemy Health Limited |
| Manufacturer: | Pharmathen International SA, Rodopi, Greece |
| Product: | CRESEMBA |
| Active Ingredient: | Isavuconazonium sulfate 186.3mg equivalent to isavuconazole 100mg |
| Dosage Form: | Capsule |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | SwissCo Services AG, Sisseln, Switzerland |
| Product: | CRESEMBA |
| Active Ingredient: | Isavuconazonium sulfate 372.6mg equivalent to isavuconazole 200mg |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Baxter Pharmaceutical Solutions LLC, Indiana, United States of America |
Dated this 15th day of August 2022.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).